Otsuka Holdings
4578.T
#742
Rank
NZ$54.28 B
Marketcap
NZ$102.79
Share price
0.11%
Change (1 day)
4.37%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: NZ$1.80 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are NZ$14.47 Billion. In 2023 the company made an earning of NZ$1.80 Billion a decrease over its 2022 earnings that were of NZ$2.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023NZ$1.80 B-20.93%
2022NZ$2.28 B-12.7%
2021NZ$2.61 B-19.92%
2020NZ$3.27 B13.9%
2019NZ$2.87 B52.07%
2018NZ$1.88 B11.22%
2017NZ$1.69 B-36.03%
2016NZ$2.65 B31.15%
2015NZ$2.02 B
2013NZ$4.19 B33.52%
2012NZ$3.14 B-4.65%
2011NZ$3.29 B45.53%
2010NZ$2.26 B